Veos operates across human health, agriculture, and environmental systems — each platform built on validated science, defensible IP, and a clear commercial path.
Each Veos platform is independently led, separately commercialized, and judged on the same standards: validated mechanism, protectable IP, identifiable buyers, and unit economics that compound.
What unites them is the operating system — how we evaluate opportunities, how we run formulation and trials, and how we get to market. That discipline is what allows three platforms to coexist without diluting any of them.
Pharmaceutical and nutraceutical products developed under clinical-grade science, manufactured in Europe, and distributed across North American and EU markets through direct-to-consumer and clinical channels.
Explore Human HealthPlant biostimulants and crop-system technologies that enhance yield, resilience, and quality across a growing portfolio of crops. Active field trials in collaboration with European research institutions.
Explore AgricultureWater treatment chemistry, critical-materials recovery, and circular-economy applications. Active development across municipal wastewater, industrial discharge, and battery and pharmaceutical capsule recycling.
Explore Environmental